HYPR News & Events

Hyperfine announced the European launch of the next-generation Swoop system powered by the latest advancement in Optive AI software. This marks a significant milestone in the company's global expansion of its most advanced portable MRI technology, supporting international commercial growth and improving global access to high-quality brain imaging at the point of care. Following CE mark and UKCA approval, the next-generation Swoop system, also known as Model 2, is now commercially available across an initial wave of European markets. Hyperfine also announced the inclusion of its next-generation Swoop system in the UniHA procurement listing, a key milestone enabling broader adoption across hospitals within the French public healthcare system. The initial inclusion of the Swoop system in this listing was in October 2025.

Hyperfine announced the formation of its Neurosurgery Advisory Council, a multidisciplinary group of neurosurgeons who will provide expertise to help inform the potential role of portable ultra-low-field MRI in neurosurgical applications. "The neurosurgical setting is becoming an important site of care for accessible imaging, where traditional MRI has intrinsic limitations. The Swoop system may open up new possibilities for integrating imaging directly into surgical workflows," said Hyperfine Chief Operating Officer Tom Teisseyre. "Providing access to imaging at key moments around a procedure may help clinical teams make better informed decisions, improve efficiency, and ultimately advance how surgical care is delivered."

Hyperfine announced the achievement of scan volume milestones in key hospitals and neurology clinics, demonstrating accelerating clinical utilization and adoption of the Swoop(R) system throughout the United States. The increasing clinical use of the Swoop system is driven by several factors: enhanced clinical utility from improved image quality, growing evidence of its economic value, and expanding adoption across new care settings, including neurology clinics and the emergency department. The most successful Swoop system programs are driven by visionary healthcare leaders who are passionate about addressing the challenges of MRI availability and recognize the clinical and economic value of portable MRI in expanding patient access to imaging. CHRISTUS Mother Frances, one of the first sites to adopt the next-generation Swoop system, crossed the 500-scan milestone in just nine months, driven by integrating the Swoop(R) system into a scalable stroke program. Clinical use of the Swoop system is accelerating in neurology offices, where it has quickly become a valuable extension of the diagnostic workflow since its introduction in mid-2025. Neurology of Central Florida has already exceeded 500 in-office MRI scans, demonstrating how point-of-care imaging enables neurologists to complete diagnostic evaluations within their own practice.